메뉴 건너뛰기
Breast Cancer Research and Treatment
Volumn 112, Issue 1, 2008, Pages 1-4
Routine prophylactic granulocyte colony stimulating factor (GCSF) is not necessary with accelerated (dose dense) paclitaxel for early breast cancer
Author keywords

Accelerated (dose dense) paclitaxel; Early breast cancer; GCSF; Prophylactic
Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
EID: 52949117711     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9826-y     Document Type: Review
Times cited : (4)
References (8)
  • 1
    • 0037687355 scopus 로고    scopus 로고
    • Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741
    • 8
    • ML Citron DA Berry C Cirrincione 2003 Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 J Clin Oncol 21 8 1431 1439
    • (2003) J Clin Oncol , vol.21 , pp. 1431-1439
    • Citron, M.L.1    Berry, D.A.2    Cirrincione, C.3
  • 2
    • 14544270307 scopus 로고    scopus 로고
    • First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study
    • 6
    • CL Vogel MZ Wojtukiewicz RR Carroll 2005 First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study J Clin Oncol 23 6 1178 1184
    • (2005) J Clin Oncol , vol.23 , pp. 1178-1184
    • Vogel, C.L.1    Wojtukiewicz, M.Z.2    Carroll, R.R.3
  • 3
    • 0037837665 scopus 로고    scopus 로고
    • Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: The National Surgical Adjuvant Breast and Bowel Project Experience
    • 7
    • RE Smith J Bryant A DeCillis 2003 Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience J Clin Oncol 21 7 1195 1204
    • (2003) J Clin Oncol , vol.21 , pp. 1195-1204
    • Smith, R.E.1    Bryant, J.2    Decillis, A.3
  • 4
    • 33847758628 scopus 로고    scopus 로고
    • Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy
    • 3
    • D Hershman AI Neugut JS Jacobson 2007 Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy J Natl Cancer Inst 99 3 196 205
    • (2007) J Natl Cancer Inst , vol.99 , pp. 196-205
    • Hershman, D.1    Neugut, A.I.2    Jacobson, J.S.3
  • 5
    • 33846912251 scopus 로고    scopus 로고
    • Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: Risk factors for leukemia and myelodysplastic syndrome after breast cancer
    • 3
    • MC Le Deley F Suzan B Cutuli 2007 Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer J Clin Oncol 25 3 292 300
    • (2007) J Clin Oncol , vol.25 , pp. 292-300
    • Le Deley, M.C.1    Suzan, F.2    Cutuli, B.3
  • 6
    • 33646783722 scopus 로고    scopus 로고
    • 2006 [cited; Available from:
    • National Cancer Institute (2006) Common terminology criteria for adverse events v3.0. 2006 [cited; Available from: http://www.ctep.cancer.gov/forms/ CTCAEv3.pdf
    • (2006) Common Terminology Criteria for Adverse Events v3.0
  • 7
    • 33744776952 scopus 로고    scopus 로고
    • Optimizing adjuvant chemotherapy in early-stage breast cancer
    • 14. discussion 1768, 1772-1774, 1777-1778
    • E Perez HB Muss 2005 Optimizing adjuvant chemotherapy in early-stage breast cancer Oncology (Williston Park) 19 14 1759 1767 discussion 1768, 1772-1774, 1777-1778
    • (2005) Oncology (Williston Park) , vol.19 , pp. 1759-1767
    • Perez, E.1    Muss, H.B.2
  • 8
    • 52949130128 scopus 로고    scopus 로고
    • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    • (abstract)
    • Sugarman S, Wasserheit C, Hodgman E et al (2006) A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC). Breast Cancer Res Treat Suppl 1:6084 (abstract)
    • (2006) Breast Cancer Res Treat Suppl , vol.1 , pp. 6084
    • Sugarman, S.1    Wasserheit, C.2    Hodgman, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.